Purchase Order N3239818P0277
Award Date 9/29/18
Potential Completion Date 9/30/19
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Belmont, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Bureau of Medicine and Surgery (BUMED), the medical branch of the Department of the Navy, awarded a $105,375 firm fixed-price purchase order to Olink Proteomics Inc. on August 19, 2024, for the Olink Signature Q100 system and related proteomics services. The award was issued as a sole source contract based on a Special Notice posted by the Naval Medical Research Command (NMRC) in July 2024. This contract supports NMRC's research initiatives focused on identifying biomarkers related to...
- The Bureau of Medicine and Surgery (BUMED) awarded a $12,990.38 firm fixed-price purchase order to Illumina, Inc. on November 11, 2025, for specialized molecular biology reagents and diagnostic kits with an ultimate completion date of February 6, 2026. The contract covers a MiSeq Reagent Nano Kit V2 (300-cycles) and an Illumina Respiratory Virus Enrichment Kit Set A, both critical components for next-generation sequencing applications. Performance will take place in San Diego, California,...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of the Navy, to Illumina, Inc. for $97,678.20. The award provides Illumina's RNA sequencing products and reagents to support the Naval Health Research Center's (NHRC) laboratory work characterizing biological threats. The contract has a period of performance through December 1, 2021. This award is not associated with a set-aside program. Illumina has previously...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Lakepharma, Inc., a minority-owned, for-profit biopharmaceutical contract development and manufacturing organization (CDMO). The $20,000 contract is for the "heavy and light humanization of 1B3 MAB", which involves antibody humanization services to support NIAID's medical research and healthcare mission. The...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $89,064.42 contract is for the delivery of genetic analysis instruments, reagents, and associated services to support BUMED's biomedical research, medical readiness, and other initiatives. Life Technologies is providing its specialized biotechnology products and...
- The U.S. Navy's Bureau of Medicine and Surgery (BUMED) awarded a firm fixed-price purchase order valued at $12,956.45 to Belomed S.R.L., a minority-owned medical and laboratory supply company based in San Miguel, Peru. The contract, effective August 7, 2025, procures reagents and consumables specifically for the Agilent TapeStation system instrument. These materials will support next-generation sequencing quality control procedures within the laboratory to ensure successful sequencing...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the Department of Defense, to Luminex Corp, a manufacturer of biological testing technologies. The contract is for $93,630.98 and is to provide laboratory supplies. The contract is not set aside for any special business type. Luminex Corp has previously received other prime contracts and subcontracts from federal agencies like the Centers for Disease Control and Prevention,...
- The U.S. Navy's Bureau of Medicine and Surgery (BUMED) awarded a $104,780.06 firm fixed-price purchase order to Fisher Scientific Company L.L.C. for the procurement of various laboratory equipment, including centrifuges, rotors, and a real-time PCR system. This contract was awarded on May 3, 2024, with a completion date of May 31, 2024. The items are intended to support BUMED's Molecular Department of the Biological Defense Research Directorate, which maintains an ISO-certified production and...
- The Department of the Navy's Bureau of Medicine and Surgery awarded a $247,866 firm fixed-price purchase order to Pathoseq Bio, LLC on July 1, 2024, for medical research and development services. This contract, set aside for total small business participation, is scheduled for completion by September 30, 2025, and will be performed in the United States Minor Outlying Islands. The award resulted from Solicitation AN42, issued by Naval Supply Systems Command, which sought health research and...
- This is a $6,891.78 firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH) to Lakepharma, Inc., a minority-owned, for-profit contract development and manufacturing organization (CDMO). The contract is for expression optimization and immunoaffinity capture (IMAC) pulldown services to support NIMH's internal research. The contract has a period of performance through September 9, 2025. There was no set-aside used for this award. Lakepharma has previously...